How will ASX shares respond to rising US inflation?

Investors will find not all shares are created equal in the face of rising prices.

ASX shares, it would seem, weren't overly worried about the sharp spike in inflation reported by the United States Labor Department on Thursday.

In Friday's trade, the All Ordinaries Index (ASX: XAO) closed up 0.24%. The All Ords is now up 8.97% so far in 2021.

A piggy bank attached a bicycle pump floats up, indicating rising inflation

Image Source: Getty Images

Biggest US inflation leap in 13 years

ASX shares were up on average despite the world's largest economy reporting a 0.6% rise in the consumer price index (CPI) in May. Year-on-year that brings the US inflation rate to 5%. That's the biggest 1-year inflation leap in the US since 2008.

On the surface that may sound rather alarming. But dig a little deeper and you'll find some rather unique reasons for the year-on-year price spike that could well mean it's a short-term issue.

eToro market analyst Josh Gilbert told the Motley Fool he expects the spike in most prices to be transient.

According to Gilbert:

Many of the drivers are one-offs, such as US inflation being at 0.1% in May 2020. Or supply disruptions, such as semiconductor chips or shipping rates due to the blocking of the Suez Canal.

We're also seeing dramatic year-over-year swings in oil, which went from near zero to US$72 a barrel, as well as broader commodity prices rises. Many of these will work themselves out in the coming months as economies and supply chains normalise. In the case of commodities, they're too small to have a large impact, as economies and inflation baskets have become a lot less commodity-dependent.

eToro is expecting US headline CPI to come in at a little over 3% in 2021 and fall back to around 2.5% next year.

Which ASX shares will struggle with higher inflation?

Gilbert points out that the news flow around inflation is leading to higher volatility in US markets. As the ASX tends to take its lead from US markets, we won't be immune here in Australia.

"Investors should expect periods of volatility over the next few months as uncertainty sweeps through the market," Gilbert told us. "Global markets see US inflation pressure as a view that rates will rise across the world sooner than expected."

So which ASX shares will face strong headwinds in a higher inflation environment?

According to Gilbert:

Growth and tech stocks are most at risk from inflation. These sectors have been the stocks in focus for the last few years. With bond yields low, we see that investors are willing to pay a premium for these stocks, as they look to capitalise on returns over several years rather than settling for lower rates with bonds. 

When bond yields rise, as we are currently seeing, investors rotate into cyclical sectors and expect much faster returns from these growth stocks. The environment we are in highlights more than ever that investors should have a diversified portfolio. Big tech is currently being supported by clean balance sheets and strong earnings that support high valuations. 

Which ASX shares could benefit with higher inflation?

The underlying concerns about inflation aren't so much that prices may rise a bit above the 2–3% annual target rate set by the Reserve Bank of Australia. It's that commercial banks will lift lending rates to at least match the pace of inflation.

If the cost of money goes up, ASX shares that have been in favour for their potential to deliver large gains down the road, even though they're unprofitable today, could find investors turning to shares that are already turning smaller profits.

Gilbert told the Motley Fool:

The focus across the broader market would be to continue to look at value stocks. Areas such as consumer discretionary, financials and energy will lead the market performance through 2021. They have more room for earnings growth, cheaper valuations and provide upside to the re-opening of economies.

Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

Man sitting in a plane seat works on his laptop.
Broker Notes

Qantas shares were just downgraded but I still rate them as a buy

I think the downgrade was wrong and see value in the airline's shares.

Read more »

Smiling miner.
Broker Notes

4 ASX mining shares with 90% to 155% upside ahead: experts

These ASX mining shares have outstanding price growth potential.

Read more »

A woman smiles at the outlook she sees through binoculars.
Broker Notes

3 ASX shares tipped by brokers to return 48% to 109% over the next 12 months

Find out which ASX share is forecast to climb the highest by this time next year.

Read more »

a water tap is turned on and showering out banknotes into the open hand of a woman below it.
Broker Notes

This ASX small cap could jump 262% over the next year, one analyst says

This water technology company is having a strong year.

Read more »

Happy woman holding an umbrella while spreading her arms out in the rain.
52-Week Highs

IAG share price hits fresh 52-week high: Is there any upside left?

The shares last passed the $9-mark in June last year.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face.
Broker Notes

Woolworths, NextDC, Telstra shares: Buy, sell, or hold?

Here’s what the experts tip for these three major ASX shares.

Read more »

Man and woman sitting at table with the man looking a bit puzzled at his laptop.
Broker Notes

Buy, hold, sell: Wisetech Global, Wesfarmers, CSL shares

Christopher Watt from Bell Potter explains his ratings on 3 ASX 200 sector heavyweights.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Broker Notes

3 buy-rated biotechnology companies, including one which could jump 400%

If you're looking for exposure to healthcare, these companies could be worth a look.

Read more »